Dive into our comprehensive technical reports covering the Fine Chemical Intermediates sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101357908B details a green one-pot method converting TPPO waste into high-purity Dibenzothiazole Disulfide and Triphenylphosphine, offering significant cost reduction.
Patent CN103664471A reveals a novel one-step synthesis of 1-cyclopropylnaphthalene from 1-vinylnaphthalene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Novel synthetic route for agrochemical intermediate offering high purity and cost efficiency. Scalable process for Pyriproxyfen production supply chain optimization.
Patent CN119874595B introduces visible light [2+1+2] cyclization. Offers mild conditions and high yield for pharmaceutical intermediates.
Patent CN108276406B reveals a metal-free route to polycyclic 2-hydropyrazoles. Achieve high purity and cost efficiency in pharmaceutical intermediate manufacturing without transition metals.
Patent CN87106588A details an efficient route for steroid derivatives. This report analyzes cost reduction in agrochemical intermediate manufacturing and supply chain scalability.
Novel alkylammonium acetate method for AcHMF. High yield, base-free process. Reliable supply chain for pharmaceutical intermediates and biomass-derived platform compounds.
Patent CN111187148A enables simultaneous production with 97% selectivity. Offers cost reduction in pharma intermediates manufacturing and enhanced supply chain reliability for global buyers.
Patent CN112552242A details a novel CuCl-catalyzed route to cinnoline salts, offering cost-effective manufacturing and scalable supply chain solutions for global buyers.
Patent CN110627769A reveals mild nicotine synthesis. Offers cost reduction and high purity for electronic chemical manufacturing and pharmaceutical intermediates.
Patent CN105399644A reveals novel chiral recognition compounds enabling high-purity separation. This process offers substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel 5-step synthesis of 4-methyl-5-(β-hydroxyethyl)-thiazole via α-acetyl-γ-butyrolactone. High yield >96%, low cost, scalable for Vitamin B1 and flavor industries.
Patent CN102249882B details a safe, four-step synthesis for cyproconazole intermediates, eliminating active metals and toxic reagents for cost-effective manufacturing.
Patent CN102249882B details a safe, scalable route for Cyproconazole intermediates, eliminating hazardous metals and reducing manufacturing costs significantly.
Patent CN106831862A introduces a novel chiral bridged ligand enhancing enantioselectivity in Suzuki reactions, offering cost-effective purification and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN114539073A reveals a cost-effective route for 3-bromo-2-chloro-4,6-difluoroaniline. Discover scalable manufacturing and supply chain advantages for API intermediates.
Patent CN102898360A reveals a high-yield synthesis of 3,5-dibromo-4-fluoropyridine from 4-aminopyridine. This breakthrough offers cost reduction in pharmaceutical intermediates manufacturing and ensures supply continuity.
Patent CN102702123B reveals a one-pot synthesis for chiral fluorinated oxazolines. This method offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN115786313B reveals enhanced nitrilase mutant for 2-chloronicotinic acid. Delivers significant yield improvements and green manufacturing advantages for supply chains.
Novel one-step alkoxycarbonylation patent reduces waste. Efficient supply chain for polymer intermediates.